Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets

Nature Nanotechnology

Volumn 8, Issue 10, 2013, Pages 735-741

  Yoon, Hyeun Joong ^a   Kim, Tae Hyun ^a   Zhang, Zhuo ^a   Azizi, Ebrahim ^a   Pham, Trinh M ^a   Paoletti, Costanza ^a   Lin, Jules ^a   Ramnath, Nithya ^a   Wicha, Max S ^a   Hayes, Daniel F ^a   Simeone, Diane M ^a   Nagrath, Sunitha ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DISEASES; GRAPHENE; NANOSHEETS; TUMORS;

BIOLOGICAL PROPERTIES; CIRCULATING TUMOUR CELLS; EFFECTIVE APPROACHES; FUNCTIONALIZED GRAPHENE; LIMITED SENSITIVITY; MICRO-FLUIDIC DEVICES; MOLECULAR CHARACTERIZATION; THREE-DIMENSIONAL STRUCTURE;

DIAGNOSIS;

GOLD; GRAPHENE OXIDE; NANOMATERIAL;

ARTICLE; CELL ISOLATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TARGET CELL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SEPARATION; FEMALE; GRAPHITE; HUMANS; LUNG NEOPLASMS; MCF-7 CELLS; MICROFLUIDIC ANALYTICAL TECHNIQUES; NANOSTRUCTURES; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84885482664     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2013.194     Document Type: Article

References (33)

1. Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. New Engl. J Med. 351, 781-791 (2004)
2. Nagrath, S. et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007)
3. Maheswaran, S. et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359, 366-377 (2008)
4. Willipinski-Stapelfeldt, B. et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res. 11, 8006-8014 (2005)
5. Bednarz-Knoll, N., Alix-Panabières, C. & Pantel, K. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev. 31, 673-687 (2012)
6. Pantel, K., Brakenhoff, R. H. & Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nature Rev. Cancer 8, 329-340 (2008)
7. Lin, H. K. et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 16, 5011-5018 (2010)
8. Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nature Nanotech. 2, 469-478 (2007)
9. Xia, X-R., Monteiro-Riviere, N. A. & Riviere, J. E. An index for characterization of nanomaterials in biological systems. Nature Nanotech. 5, 671-675 (2010)
10. Wang, S. et al. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew. Chem. Int. Ed. 121, 9132-9135 (2009)
11. Lee, S-K. et al. Nanowire substrate-based laser scanning cytometry for quantitation of circulating tumor cells. Nano Lett. 12, 2697-2704 (2012)
12. Zhang, N. et al. Electrospun TiO2 nanofiber-based cell capture assay for detecting circulating tumor cells from colorectal and gastric cancer patients. Adv. Mater. 24, 2756-2760 (2012)
13. Liu, Z., Robinson, J. T., Sun, X. & Dai, H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876-10877 (2008)
14. Mohanty, N. & Berry, V. Graphene-based single-bacterium resolution biodevice and DNA transistor: interfacing graphene derivatives with nanoscale and microscale biocomponents. Nano Lett. 8, 4469-4476 (2008)
15. Ramanathan, T. et al. Functionalized graphene sheets for polymer nanocomposites. Nature Nanotech. 3, 327-331 (2008)
16. Dreyer, D. R., Park, S., Bielawski, C.W. & Ruoff, R. S. The chemistry of graphene oxide. Chem. Soc. Rev. 39, 228-240 (2010)
17. Sun, X. et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1, 203-212 (2008)
18. Eda, G., Fanchini, G. & Chhowalla, M. Large-area ultrathin films of reduced graphene oxide as a transparent and flexible electronic material. Nature Nanotech. 3, 270-274 (2008)
19. Li, X. et al. Highly conducting graphene sheets and Langmuir-Blodgett films. Nature Nanotech. 3, 538-542 (2008)
20. Wang, H.,Wang, X., Li, X. & Dai, H. Chemical self-assembly of graphene sheets. Nano Res. 2, 336-342 (2009)
21. Sieuwerts, A. M. et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl Cancer Inst. 101, 61-66 (2009)
22. Salic, A. & Mitchison, T. J. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc. Natl Acad. Sci. USA 105, 2415-2420 (2008)
23. Lustberg, M., Jatana, K. R., Zborowski, M. & Chalmers, J. J. Emerging technologies for CTC detection based on depletion of normal cells. Recent Results Cancer Res. 195, 97-110 (2012)
24. Stott, S. L. et al. Isolation of circulating tumor cells using a microvortexgenerating herringbone-chip. Proc. Natl Acad. Sci. USA 107, 18392-18397 (2010)
25. Mego, M. et al. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. Int. J. Cancer 129, 417-423 (2011)
26. Alix-Panabières, C., Schwarzenbach, H. & Pantel, K. Circulating tumor cells and circulating tumor DNA. Annu. Rev. Med. 63, 199-215 (2012)
27. Ozkumur, E. et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5, 179ra147 (2013)
28. Krebs, M. G. et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J. Thorac. Oncol. 7, 306-315 (2012)
29. Edgerton, S. M., Moore, D. II, Merkel, D. & Thor, A. D. erbB-2 (HER-2) and breast cancer progression. Appl. Immunohistochem. Mol. Morphol. 11, 214-221 (2003)
30. Amir, E. et al. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies. Cancer Treat. Rev. 38, 708-714 (2012)
31. Fehm, T. et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res. Treat. 124, 403-412 (2010)
32. Riethdorf, S. et al. Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin. Cancer Res. 16, 2634-2645 (2010)
33. Pestrin, M. et al. Final results of a multicenter phase II clinical trial evaluating the activity of single-agent Lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study. Breast Cancer Res. Treat. 134, 283-289 (2012)